Praxis Precision Medicines, Inc. (PRAX)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 · 99.2 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-07) · 99.1 · 99.2 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-19) · 99.1 | 8-K (2026-01-06) | ||
| 10-Q | Q3-2025 | 8-K (2025-11-05) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-04) · 99.1 · 99.2 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-02) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-28) · 99.1 | 8-K (2025-01-29) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-06) · 99.1 · 99.2 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-13) · 99.1 · 99.2 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-13) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-05) · 99.1 · 99.2 | 8-K (2024-01-10) | ||
| 10-Q | Q3-2023 | 8-K (2023-11-07) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Condensed Consolidated Statements of Operations (unaudited) (P) | — |
|
| Consolidated Statements of Comprehensive Loss | ||
| Consolidated Statements of Stockholders' Equity | ||
| Consolidated Statements of Stockholders' Equity (P) | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accrued Expenses | ||
| Cash Equivalents and Marketable Securities | ||
| Collaboration and License Agreements | ||
| Collaboration License Agreements | — |
|
| Commitments and Contingencies | ||
| Common Stock and Preferred Stock | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Employee Benefit Plan | — |
|
| Fair Value Measurements | — |
|
| Fair Value of Financial Assets | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Marketable Securities | ||
| Nature of The Business | ||
| Net Loss Per Share | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment, Net | — |
|
| Related Party Transactions | ||
| Restricted Cash | — |
|
| Restructuring | ||
| Segment Information | ||
| Segment Reporting | — |
|
| Significant Agreements | — |
|
| Stock-based Compensation | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| Ucb Option and License Agreement | ||